Peter Rippey, MD
Sports Medicine · Mobile, ALNPI 1477715712
Payments from drug & device makers
What this record shows
This record is dominated by grants: $6,500 of the $6,900 with a category attached, or 94.2%. DJO, LLC accounts for 94.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $6,549 and has fallen 98.1% since, to $124 in 2025.
Across 21 payments — averaging $328.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- DJO, LLC$7K
- Pacira Pharmaceuticals Incorporated$122
- Hologic Sales And Service, LLC$34
- GSK$32
- Boston Scientific$30
- Pfizer$25
- plus $133 from 9 others
What the payments were for
- Grants$6,50094%
- Food & beverage$4006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| DJO, LLC | 3 | $6,524 |
| Pacira Pharmaceuticals Incorporated | 1 | $122 |
| Hologic Sales And Service, LLC | 1 | $34 |
| GSK | 2 | $32 |
| Boston Scientific | 2 | $30 |
| Pfizer | 2 | $25 |
| Amgen | 2 | $25 |
| Johnson & Johnson | 1 | $18 |
| Global Blood Therapeutics, Inc. | 1 | $16 |
| Bioventus LLC | 1 | $14 |
| Corcept Therapeutics | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Gilead | 1 | $12 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXPAREL$122
How this compares
$6,900 in reported general payments places this provider in the 60th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $486 |
| Diclofenac Sodium | 34 | $406 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $388 |
| Gabapentin | 11 | $207 |
| Atorvastatin Calcium | 26 | $188 |
| Sertraline Hcl | 15 | $114 |
| Hydrochlorothiazide | 12 | $55 |
| Trazodone Hcl | 13 | $54 |
| Amlodipine Besylate | 19 | $45 |
| Losartan Potassium | 11 | $18 |
| Lisinopril | 11 | $9 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Mobile
- Price SessumsMobile$21K
- Terry ClayMobile$21K
- Matthew SkinnerMobile$6K
- Jeffrey ConradMobile$5K
- Edward CainBirmingham$12.7M
- Daniel MatthewsDaphne$190K
- Mark RogersBirmingham$94K
- Amit MomayaBirmingham$77K
- Matthew SmithGuntersville$73K
- Christoper GarrettBirmingham$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.